Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Verapamil hydrochloride
Dexcel-Pharma Ltd
C08DA01
Verapamil hydrochloride
240mg
Modified-release tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 02060200; GTIN: 5033847000211
PACKAGE INFORMATION LEAFLET PLEASE READ THIS LEAFLET CAREFULLY BEFORE YOU START TAKING YOUR TABLETS. • Keep this leaflet. You may need to read it again. • If you have any further questions ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. IN THIS LEAFLET: 1. What Verapress MR 240 Tablets are and what they are used for 2. What you need to know before you take Verapress MR 240 Tablets 3. How to take Verapress MR 240 Tablets 4. Possible side effects 5. How to store Verapress MR 240 Tablets 6. Contents of the pack and other information 1. WHAT VERAPRESS MR 240 TABLETS ARE AND WHAT THEY ARE USED FOR THE NAME OF YOUR MEDICINE IS: Verapress MR 240 Tablets Verapress MR 240 Tablets belong to a group of medicines called calcium channel blockers. Calcium channel blockers change the amount of calcium getting into the muscle cells in your heart and blood vessels. This can change the strength and speed with which your heart beats. It also opens up the blood vessels so blood can be pumped around the body more easily. This helps more oxygen to get to your heart muscle and can lower your blood pressure. Verapress MR 240 Tablets are indicated for the treatment of mild to moderate hypertension (high blood pressure) and the treatment and prevention of angina pectoris (chest pain). 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE VERAPRESS MR 240 TABLETS IF YOU ARE UNSURE IF ANY OF THE LISTS APPLIES TO YOU, ASK YOUR DOCTOR BEFORE YOU START TO TAKE YOUR TABLETS. DO NOT TAKE VERAPRESS MR 240 TABLETS: • If you are allergic (hypersensitive) to Verapamil Hydrochloride or to any of the other ingredients of Verapress MR 240 Tablets (listed in section 6 - Further information). • If you are having a cardiogenic shock (a sudden and rapid fall in blood pressure). • If you are ha Read the complete document
OBJECT 1 VERAPRESS MR 240 TABLETS Summary of Product Characteristics Updated 04-Aug-2017 | Dexcel Pharma Ltd 1. Name of the medicinal product Verapress MR 240 tablets 2. Qualitative and quantitative composition Verapamil HCI 240.0 mg Also contains microcrystalline cellulose and about 32 mg of sodium. For a full list of excipients, see section 6.1. 3. Pharmaceutical form Modified-Release tablets The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4. Clinical particulars 4.1 Therapeutic indications Verapress MR 240 is indicated for the treatment of mild to moderate hypertension, and for the treatment and prophylaxis of angina pectoris. 4.2 Posology and method of administration _Adults:_ HYPERTENSION: Most patients respond to 240 mg daily (one tablet) given as a single dose. If control is not achieved after a period of at least one week the dosage may be increased to a maximum of two Verapress MR 240 tablets daily (one in the morning and one in the evening at an interval of about twelve hours). A further reduction in blood pressure may be achieved by combining Verapress MR 240 with other anti- hypertensive agents, in particular diuretics. ANGINA PECTORIS: One tablet of Verapress MR 240 twice daily. A small number of patients respond to a lower dose and where indicated, adjustment down to one tablet of Verapress MR 240 daily could be made. _Elderly patients_: The adult dose is recommended unless renal or hepatic function is impaired (see Section 4.4, 'Special Warnings and Precautions for Use'). The tablets should not be chewed. _Children: _Verapress MR 240 is not recommended for children. Liver impairment In patients with impaired liver function, metabolism of the drug is delayed to a greater or lesser extent depending on the severity of hepatic dysfunction, thus potentiating and prolonging the effects of verapamil hydrochloride. Therefore, the dosage needs to be adjusted with special caution in patients with impaired liver function and low doses should be given in Read the complete document